Publications by the researcher in collaboration with Pedro Jesús Serrano Castro (11)

2023

  1. Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program

    Epilepsia Open, Vol. 8, Núm. 3, pp. 918-929

2022

  1. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy

    Epilepsy and Behavior, Vol. 137

2020

  1. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations

    Neurologia, Vol. 35, Núm. 2, pp. 115-125

  2. Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey

    Neurologia, Vol. 35, Núm. 4, pp. 252-257

2019

  1. Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit

    Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428

2018

  1. Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study

    Revista Clinica Espanola, Vol. 218, Núm. 7, pp. 327-335

  2. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures

    Acta Neurologica Scandinavica, Vol. 138, Núm. 2, pp. 122-129

2017

  1. Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain

    Revista de Neurologia, Vol. 65, Núm. 8, pp. 361-367

  2. Eslicarbazepine acetate and carotid intima-media thickness in epileptic patients

    Epilepsy Research, Vol. 138, pp. 81-87

2015

  1. Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

    Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131

1997

  1. Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases

    Brain, Vol. 120, Núm. 7, pp. 1105-1113